Rheumatoid arthritis
80 results
1 - 80
2010 classification criteria for rheumatoid arthritis- Updated ACR guideline on managing patients with rheumatoid arthritis
- No increased risk of cancer with biologic therapy for rheumatoid arthritis
- MA: ultrasound is reasonably accurate in detecting synovitis in patients with rheumatoid arthritis
- Atorvastatin = placebo for primary prevention of CV events in patients with rheumatoid arthritis
- Adding MTX to sulfasalazine better for RA (MASCOT)
- Flu vaccine not associated with flares in patients with rheumatoid disorders
- Guidelines: Management of RA
- Biologicals improve outcomes in patients with RA
- Disease-specific CV risk scores = general CV risk scores in patients with RA
- RA options: MTX still first-line
- Hand exercises modestly improve function in patients with RA (SARAH)
- Synovial WBC and percent PMNs best for septic arthritis diagnosis
- MTX associated with decreased CVD risk in patients with RA
- RA factors + CVD risk factors modestly accurate in predicting CVD events in patients with RA
- Acupuncture effective for chronic shoulder pain
- Zoster vaccine not associated with increased risk of HZ infection in immune-mediated disease patients
- Vitamin D supplementation: good for bones and fall prevention, but little else
- Omega-3 fatty acids have small analgesic effect
- Antidepressants helpful in chronic rheumatic and other pain disorders
- EULAR/ACR guideline on managing patients with polymyalgia rheumatica
- Placebo plus message of benefit decreases chronic low back pain
- Topical steroids plus baricitinib is more effective than steroids alone for atopic dermatitis
- Etanercept effective for plaque psoriasis in children
- Baricitinib is effective for severe alopecia areata, but long-term safety is not known
- NSAID use associated with increased risk of serious bleeding and CV events after MI
- Celecoxib, naproxen, and ibuprofen have similar CV safety (PRECISION)
- Overview of new ACC/AHA lipid guidelines: here we go again